ArticleAJOG global reports2026
Screening performance of quantitative blood loss for postpartum anemia among patients without baseline anemia.
Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundQuantitative blood loss (QBL) is widely used to identify postpartum hemorrhage. Although higher blood loss is expected to be associated with greater hemoglobin (Hb) decline, the strength of this relationship and the diagnostic performance of commonly used thresholds for postpartum anemia are not well defined. Further evaluation is needed to define the utility and limitations of QBL in the postpartum assessment.
objectiveTo evaluate the association between QBL and postpartum hematologic outcomes, including postpartum anemia and Hb decline, and to assess the diagnostic performance of commonly used QBL thresholds. STUDY
designThis retrospective cohort study included singleton deliveries at an urban safety-net hospital in 2023 with documented QBL and available baseline and postpartum Hb values. Patients with baseline anemia, transfusion before postpartum Hb measurement, or conditions expected to substantially alter bleeding risk or Hb levels independently of delivery blood loss were excluded. Multivariable logistic regression was used to evaluate associations between QBL and postpartum anemia, defined as Hb<10 g/dL, and multivariable linear regression was used to evaluate Hb decline. Diagnostic performance of QBL thresholds was assessed separately by delivery mode using sensitivity, specificity, positive predictive value, negative predictive value, and receiver operating characteristic analysis.
resultsAmong 769 deliveries, postpartum anemia occurred in 22.0% (169/769), and severe postpartum anemia, defined as Hb<8 g/dL, occurred in 0.5% (4/769). In adjusted models, compared with QBL<500 mL, higher QBL categories were associated with increased odds of postpartum anemia: 500 to 999 mL, adjusted odds ratio (aOR) 5.13 (95% confidence interval [CI], 2.59-10.13;
conclusionAmong patients without baseline anemia, higher QBL was associated with postpartum anemia and greater Hb decline; however, QBL alone had limited screening performance. Overall, the ≥500-mL threshold failed to identify 40.2% (68/169) of postpartum anemia cases, and its sensitivity and specificity varied markedly by delivery mode. Postpartum complete blood count testing decisions should be individualized and incorporate QBL alongside baseline Hb, maternal symptoms, delivery characteristics, and clinical judgment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.